Literature DB >> 2229566

Case of anaphylaxis and four cases of allergic reaction following Gd-DTPA administration.

O L Salonen1.   

Abstract

Although Gd-diethylenetriamine pentaacetic acid (Gd-DTPA) is considered to be safe and well tolerated by patients, we have seen adverse reactions in 5 of 344 cases. This paper reports those five cases of reactions to intravenous Gd-DTPA injection.

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2229566     DOI： 10.1097/00004728-199011000-00008

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN： 0363-8715            Impact factor:   1.826


  5 in total

1.  Randomised double blind trial of the safety and efficacy of two gadolinium complexes (Gd-DTPA and Gd-DOTA).

Authors:  P Brugières; A Gaston; H R Degryse; P M Parizel; A M de Schepper; I Berry; C Manelfe; F Le Bras; C Marsault; W Wichmann
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

2.  Gadodiamide injection as a contrast medium for MRI of the central nervous system: a comparison with gadolinium-DOTA.

Authors:  D Balériaux; C Matos; D De Greef
Journal:  Neuroradiology       Date:  1993       Impact factor: 2.804

Review 3.  Actual clinical use of gadolinium-chelates for non-MRI applications.

Authors:  Holger M Strunk; H Schild
Journal:  Eur Radiol       Date:  2004-02-10       Impact factor: 5.315

4.  Arterial angiography in high-kilovoltage technique with gadolinium as the contrast agent: first clinical experience.

Authors:  F Fobbe; F Wacker; S Wagner
Journal:  Eur Radiol       Date:  1996       Impact factor: 5.315

5.  Incidental MRI findings of acute gadolinium hypersensitivity.

Authors:  C Amene; L A Yeh-Nayre; C E Dory; J R Crawford
Journal:  Case Rep Neurol       Date:  2012-04-24
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.